Papilocare, 21

Papilocare vaginal gel for restoration of the epithelium of the transition (transformation) zone of the cervix for the prevention and supportive treatment of lesions (mucosal injury) caused by HPV.

It creates a protective barrier in the transition zone of the cervix to prevent the risk of HPV infection. It improves the healing process if the gel is used as a supportive agent during the treatment of intraepithelial lesions caused by HPV on the mucous membrane of the cervix and vagina.

• control and restoration of the epithelium of the transition zone of the cervix to prevent lesions caused by HPV (LSIL)
• supportive treatment of intraepithelial lesions caused by HPV
• healing and restoration of the epithelium of lesions of the mucous membrane of the cervix and vagina
• treatment of dryness of the mucous membrane of the cervix and vagina
• restoring the balance of the vaginal microflora
• improving the condition of the vagina
• creation of conditions for rapid healing of lesions that occurred due to burning or itching

Usage

Insert the disposable tube with the applicator into the vagina, preferably before going to bed at night. Start the treatment after the end of the menses, i.e. the first month of treatment every day for 21 consecutive days, then stop for 7 days or interrupt the treatment for the period of menstruation.

For the next five months (i.e. from the 2nd to the 6th month of treatment), continue the application every other day (again, always stop at the time of menses).

Composition

Hyaluronic acid niosomes, β-glucan niosomes, Asian umbilical cord phytosomes, Coriolus versicolor extract, bioecolia Indian Zederach extract, Aloe vera extract, gel-forming components.

Warnings

Before use carefully study the instructions for use.